16
Participants
Start Date
June 29, 2021
Primary Completion Date
December 22, 2022
Study Completion Date
December 22, 2022
Ravulizumab
Body weight-based doses of ravulizumab will be administered intravenously as loading dose regimen followed by maintenance dosing every 8 weeks.
Placebo
Matching placebo
Best Supportive Care
Participants will receive medications, therapies, and interventions per standard hospital treatment protocols (unless specifically prohibited by the protocol).
Research Site, Brussels
Research Site, Belgium
Research Site, Edegem
Research Site, Leuven
Research Site, Liège
Research Site, Seoul
Research Site, New York
Research Site, Valhalla
Research Site, Taipei
Research Site, Pittsburgh
Research Site, Granada
Research Site, Philadelphia
Research Site, Washington D.C.
Research Site, New Taipei City
Research Site, Bergamo
Research Site, Morgantown
Research Site, Winston-Salem
Research Site, Madrid
Research Site, Hanover
Research Site, Gainesville
Research Site, Bordeaux
Research Site, Las Palmas de Gran Canaria
Research Site, Tours
Research Site, Louisville
Research Site, Taichung
Research Site, Lexington
Research Site, Taichung
Research Site, Daegu
Research Site, Columbus
Research Site, Cleveland
Research Site, Cleveland
Research Site, Essen
Research Site, Rochester
Research Site, Lille
Research Site, Gwangju
Research Site, Chambéry
Research Site, Paris
Research Site, Paris
Research Site, Kaohsiung City
Research Site, Salt Lake City
Research Site, Tucson
Research Site, Orange
Research Site, Kaohsiung City
Research Site, Boston
Research Site, Boston
Research Site, Boston
Research Site, Belo Horizonte
Research Site, Botucatu
Research Site, Campinas
Research Site, Fortaleza
Research Site, Porto Alegre
Research Site, Ribeirão Preto
Research Site, Salvador
Research Site, São Paulo
Research Site, São Paulo
Research Site, Kingston
Research Site, Toronto
Research Site, Montreal
Research Site, Québec
Research Site, Montpellier
Research Site, Roma
Research Site, Bunkyō City
Research Site, Iruma-Gun
Research Site, Mitaka-shi
Research Site, Miyazaki
Research Site, Nagoya
Research Site, Nagoya
Research Site, Osaka
Research Site, Sapporo
Research Site, Sendai
Research Site, Shinjuku-ku
Research Site, Amsterdam
Research Site, Groningen
Research Site, Maastricht
Research Site, Nijmegen
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Seoul
Research Site, Barcelona
Research Site, Bristol
Research Site, Carshalton
Research Site, Exeter
Research Site, Leicester
Research Site, Liverpool
Research Site, London
Research Site, London
Research Site, London
Research Site, London
Research Site, London
Research Site, Manchester
Research Site, Newcastle upon Tyne
Research Site, Nottingham
Research Site, Oxford
Research Site, Salford
Research Site, Stevenage
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY